ApiJect - Global Manufacturing Supply Chain Resiliency - Brochure

COVID-19 has shown that pharma companies need to make their complex and inefficient global supply chains more resilient. With high-value therapeutics at stake, having a flexible, resilient, and robust manufacturing supply chain is more impor tant than ever. At ApiJect, we have created a compact and flexible supply chain that can be almost entirely domestic in major markets. This is because we rely on two robust manufacturing technologies to make our platform: Blow-Fill-Seal (BFS) aseptic filling and plastic injection molding. It was one of the primary reasons the U.S. Government began supporting ApiJect R&D for potentially faster bio-emergency response even prior to COVID-19.